Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An autosomal recessive, multisystem condition caused by pathogenic variants of the PNPLA6 gene that characterized by peripheral neuropathy, cognitive impairment, lower limb spasticity, muscle weakness, and reduced vibration sense. Additional clinical features may include cerebellar ataxia, hypogonadism, growth hormone deficiency, and hypothyroidism.
Biomarker and diagnostic research for PNPLA6-related spastic paraplegia with or without ataxia has been reported in the published literature.
No clinical trials have been registered for PNPLA6-related spastic paraplegia with or without ataxia.
201 publications have been identified in PubMed for PNPLA6-related spastic paraplegia with or without ataxia. Kisho has analyzed 146 by research type. Research spans Review / Meta-Analysis (31%), Basic Science / Preclinical (20%), and Epidemiology / Natural History (20%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 45 | 31% |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 5:34 PM UTC
Common questions about PNPLA6-related spastic paraplegia with or without ataxia
Laboratory research |
29 |
20% |
Disease patterns and progression | 29 | 20% |
Patient case studies | 18 | 12% |
Testing and diagnosis research | 16 | 11% |
Clinical study results | 6 | 4% |
Other research | 3 | 2% |
Romano LE (2026). [PMID: 41771688](https://pubmed.ncbi.nlm.nih.gov/41771688/). *Life Sci Alliance*. [Basic Science / Preclinical]
Petit E (2026). [PMID: 41150672](https://pubmed.ncbi.nlm.nih.gov/41150672/). *Brain*. [Diagnostic / Biomarker]
Erdmann H (2026). [PMID: 40898875](https://pubmed.ncbi.nlm.nih.gov/40898875/). *Brain*. [Epidemiology / Natural History]
Alm V (2026). [PMID: 41603480](https://pubmed.ncbi.nlm.nih.gov/41603480/). *Eur J Neurol*. [Epidemiology / Natural History]
Xu M (2026). [PMID: 41421454](https://pubmed.ncbi.nlm.nih.gov/41421454/). *Neurobiol Dis*. [Epidemiology / Natural History]
Peppel L (2026). [PMID: 40350965](https://pubmed.ncbi.nlm.nih.gov/40350965/). *J Neuropsychiatry Clin Neurosci*. [Other]
Zadigue-Dubé É (2026). [PMID: 42025368](https://pubmed.ncbi.nlm.nih.gov/42025368/). *Curr Top Dev Biol*. [Review / Meta-Analysis]
Joffily L (2026). [PMID: 40790250](https://pubmed.ncbi.nlm.nih.gov/40790250/). *Ear Hear*. [Review / Meta-Analysis]
Yeow D (2026). [PMID: 41353788](https://pubmed.ncbi.nlm.nih.gov/41353788/). *Ann Clin Transl Neurol*. [Case Report / Case Series]
Ariello LE (2026). [PMID: 41387161](https://pubmed.ncbi.nlm.nih.gov/41387161/). *Neurotherapeutics*. [Review / Meta-Analysis]